Delivery Order SPE2DB25D3404-SPE2DB25FUPCU
Award Date
7/2/25
Potential Completion Date
7/3/25
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,411.84 firm fixed-price delivery order is for the supply of COSENTYX 300 MG DOSE-2 SYRINGEML, a pharmaceutical product. The contract has an ultimate completion date of February 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $19,886.26 for the supply of COSENTYX 300 MG DOSE-2 SYRINGEML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of July 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,574.56 Firm Fixed Price Delivery Order is for the supply of COSENTYX 300 MG DOSE-2 SYRINGEML, a specialty pharmaceutical product. The contract has a period of performance through February 26, 2025 and was awarded on February 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a $3,910.45 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of COSENTYX 300 MG DOSE-2 SYRINGE/ML, a medication, with a performance period through July 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,711.84 Firm Fixed Price Delivery Order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $12,881.48 firm-fixed-price delivery order is for the supply of COSENTYX 300 MG DOSE-2 SYRINGE, a specialty drug medication. The contract has an ultimate completion date of October 10, 2024. Amerisourcebergen holds several significant Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, which serve as primary vehicles for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,197.00 firm-fixed-price delivery order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product. The contract has an ultimate completion date of June 4, 2025 and does not use a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a significant vendor for the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,820.90 firm-fixed-price contract is for the delivery of COSENTYX 300 MG DOSE-2 SYRINGEML, a pharmaceutical product, with an ultimate completion date of June 6, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,337.16 contract is for the supply of COSENTYX 300 MG DOSE-2 SYRINGE/ML, a medication used to treat certain medical conditions. The contract has an ultimate completion date of April 28, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of COSENTYX 300 MG DOSE-2 SYRINGEML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $28,850.55 and a completion date of October 30, 2024. The contract is not a set-aside and is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...